dsip umich Introducing the D-SIP class of 2025! University of Michigan Division of

Research formulations frequently consider the carriers penetration characteristics alongside the nominal peptide concentration, because the effective topical GHK-Cu administration depends on both

Phase 3 trials have now initiated for overweight and obesity at this point, assessing CagriSema in larger numbers and for longer periods of time. References: Frias JP, et al

doi:10.1021/acs.jmedchem.1c00565 What is Cagrilintide (10mg)

Furthermore, tauro-CA (TCA) has been reported to suppress G6pc expression in primary hepatocytes 25

Transdermal iontophoretic delivery of lysine-proline-valine (KPV) peptide across microporated human skin